Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and efficacy of currently used drug therapies for treatment of lymphomas in patients with Sjögren's disease, a scoping review.

Expert opinion on drug safety·2026
Same author

Sex differences in patient-reported outcome measures and clinical parameters in patients with Sjögren's disease.

Seminars in arthritis and rheumatism·2026
Same author

Value of Oral Health Assessments for Older People with Memory Complaints Visiting a Memory Clinic for a Comprehensive Geriatric Assessment: A Cross-Sectional Study.

International journal of environmental research and public health·2026
Same author

Implant Placement and Immediate Provisionalization After Alveolar Ridge Reconstruction in the Aesthetic Zone Using a Digital Workflow: A 1-Year Prospective Case Series Study.

Clinical oral implants research·2026
Same author

Immunological signatures in patients with Sjögren's disease: association with systemic disease activity at diagnosis.

Clinical and experimental rheumatology·2025
Same author

Sex disparities in the phenotype at diagnosis of Sjögren's disease: artificial intelligence-driven characterisation in 17,416 patients.

Clinical and experimental rheumatology·2025

Related Experiment Video

Updated: May 26, 2026

Examination of Oral Candida Infection in Primary Sjögren's Syndrome Patients
05:26

Examination of Oral Candida Infection in Primary Sjögren's Syndrome Patients

Published on: March 1, 2024

Current and future challenges in primary Sjögren's syndrome.

Arjan Vissink1, Hendrika Bootsma, Fred K L Spijkervet

  • 1Department of Oral and Maxillofacial Surgery, University Medical Center Groningen, University of Groningen, The Netherlands.

Current Pharmaceutical Biotechnology
|January 3, 2012
PubMed
Summary

Sjögren's syndrome (SS) is an autoimmune disorder affecting exocrine glands, causing dry eyes and mouth. Advances in salivary diagnostics and biological therapies offer new hope for diagnosis and treatment monitoring in SS patients.

More Related Videos

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Related Experiment Videos

Last Updated: May 26, 2026

Examination of Oral Candida Infection in Primary Sjögren's Syndrome Patients
05:26

Examination of Oral Candida Infection in Primary Sjögren's Syndrome Patients

Published on: March 1, 2024

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Area of Science:

  • Immunology
  • Rheumatology
  • Oral Medicine

Background:

  • Sjögren's syndrome (SS) is an autoimmune inflammatory disorder primarily affecting exocrine glands, notably lacrimal and salivary glands.
  • Common symptoms include dry eyes and dry mouth, but systemic symptoms like fatigue, purpura, polyneuropathy, and arthritis are also prevalent.
  • A significant concern is the increased risk of lymphoma, particularly marginal zone B-cell lymphomas, in approximately 7.5% of patients.

Purpose of the Study:

  • To review recent breakthroughs in salivary diagnostics for Sjögren's syndrome.
  • To explore the potential of salivary proteomics, genomics, and systems biology in understanding SS pathophysiology.
  • To discuss the promise of biological therapies, especially B cell depletion, and personalized treatment selection in SS.

Main Methods:

  • Review of recent scientific literature on Sjögren's syndrome.
  • Analysis of advancements in salivary diagnostics for disease detection and monitoring.
  • Examination of emerging insights from salivary -omics and systems biology approaches.

Main Results:

  • Salivary diagnostics are evolving for SS diagnosis, disease activity monitoring, and treatment response assessment.
  • Salivary proteomics, genomics, and systems biology provide deep insights into SS pathophysiology.
  • B cell depletion therapy shows promise for a subset of SS patients, enabling personalized treatment strategies.

Conclusions:

  • Salivary diagnostics, combined with disease activity assessment tools, can help identify SS patients who will respond to specific biological therapies.
  • Future research holds promise for improved diagnostic and therapeutic interventions for Sjögren's syndrome.
  • Understanding SS mechanisms through -omics and systems biology is crucial for developing effective biological treatments.